James R. Kasinger Crispr Therapeutics Ag (CRSP) insider trading activity
James R. Kasinger is General Counsel and Secretary of CRISPR Therapeutics AG. Currently has a direct ownership of 81,729 shares of CRSP, which is worth approximately $3.34 Million. The most recent transaction as insider was on Mar 21, 2025, when has been sold 3,185 shares (Common Shares) at a price of $41.23 per share, resulting in proceeds of $131,317. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
81.7K
30.56%
3M change
33.6%
12M change
Total Value Held
$3.34 Million
JAMES R. KASINGER Transaction History
JRK
James R. Kasinger
General Counsel and Secretary
Cambridge, MA